Gilead Sciences, Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $114.77 on 03/03/25, and the lowest price during that time was $62.07, recorded on 05/31/24. 52-week price history of GILD Stock A stock’s 52-week high and low
Gilead Sciences, Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $111.03 on 02/24/25 and a low of $62.07 for the same time frame on 05/31/24. 52-week price history of GILD Stock Studying a stock’s 52-week price
Gilead Sciences, Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $106.69 on 02/14/25, while the lowest price for the same duration was marked at $62.07 on 05/31/24. 52-week price history of GILD Stock A stock’s
Gilead Sciences, Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $100.51 on 02/05/25, while the lowest price for the same period was registered at $62.07 on 05/31/24. 52-week price history of GILD Stock A stock’s
In terms of market performance, Gilead Sciences, Inc had a somewhat regular. The highest value for the stock in the past year was $98.90 on 02/03/25, while the lowest value was $62.07 on 05/31/24. 52-week price history of GILD Stock A stock’s 52-week high and
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded an increase of 3.23%. However, over the last six months, the performance has been weaker
In terms of market performance, Gilead Sciences, Inc had a somewhat regular. The highest value for the stock in the past year was $98.90 on 11/11/24, while the lowest value was $62.07 on 05/31/24. 52-week price history of GILD Stock Analyzing the 52-week price history
The healthcare firm Gilead Sciences Inc. (GILD) has lost nearly 5 percent of its stock over the past year. This arose even after the company’s drug was approved for COVID-19 therapy. Gilead Sciences specializes in the prevention of HIV as well as infectious diseases, including
All rights reserved © 2024, Powered By Smart TechOne
